This announcement is a separate document:
泰格医药：2024年第二次临时股东大会、2024年第一次A股类别股东会议及2024年第一次H股类别股东会议法律意见书
Hangzhou Tigermed Consulting: Legal opinions of the 2024 Second Extraordinary General Meeting of Shareholders, the 2024 First Class A Shareholders' Meeting, and the 2024 First Class H Shareholders' Meeting
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.